NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT00025415 2013-02-07Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionNational Cancer Institute (NCI)Phase 1 Completed60 enrolled